The deficiency notifications, received on August 27, follow a 30-day review period ending in late August. During this time, Scage Future failed to maintain the required US$50 million in Market Value of Listed Securities and the US$15 million minimum for publicly held shares. Nasdaq also noted that the company currently misses the threshold for total assets and revenue standards.

Despite these warnings, the company's American depositary shares continue to trade under the ticker SCAG. Scage Future has until February 23, 2027, to regain compliance by maintaining the required valuation levels for at least ten consecutive business days. Management is currently evaluating options, including a potential transfer of its listing to The Nasdaq Capital Market. This latest challenge compounds existing issues for the firm, which is already working to address previous Nasdaq notices regarding minimum bid prices and audit committee composition, with deadlines approaching in December 2026.